Skip to content

Author

N. V. Lomakin

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Comparative clinical and laboratory study of the original and generic platelet P2Y12 inhibitor ticagrelor in patients with stable coronary artery disease

Aim . To compare the laboratory (pharmacodynamic) efficacy, plasma concentrations, and safety of the original ticagrelor (OT, Brilinta) and generic ticagrelor (GT, Cardibrilin) at a dose of 60 mg twice daily in patients with stable coronary artery disease (CAD) at high ischemic risk. Material and methods . Thi...

A. A. Shebankov, N. V. Lomakin, I. Zotova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.